AD9: ADP METAVANADATE
AD9 is a Ligand Of Interest in 7B19 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 7B19_AD9_A_801 | 59% | 3% | 0.184 | 0.969 | 4.48 | 1.61 | 11 | 5 | 0 | 0 | 100% | 1 |
| 2JJ9_AD9_A_1694 | 87% | 24% | 0.106 | 0.98 | 1.93 | 1.19 | 5 | 2 | 1 | 0 | 100% | 1 |
| 3MJX_AD9_A_900 | 85% | 23% | 0.113 | 0.98 | 1.87 | 1.3 | 4 | 3 | 0 | 0 | 100% | 1 |
| 2XO8_AD9_A_1779 | 83% | 17% | 0.115 | 0.974 | 2.01 | 1.59 | 6 | 2 | 1 | 0 | 100% | 1 |
| 2X9H_AD9_A_1001 | 83% | 24% | 0.119 | 0.977 | 1.42 | 1.67 | 2 | 4 | 2 | 0 | 100% | 1 |
| 3MNQ_AD9_A_900 | 77% | 25% | 0.134 | 0.973 | 1.81 | 1.26 | 5 | 3 | 1 | 0 | 100% | 1 |
